Literature DB >> 27905143

Characterization of adverse drug reactions causing admission to an intensive care unit.

Camilo Rojas-Velandia1, Jair Ruiz-Garzón2, Juan-Carlos Moscoso-Alcina3, Álvaro Vallejos-Narvaéz4, Jenny Castro-Canoa5,6, Yuri Bustos-Martínez5, Max Flórez-Cutiva2, Mabel Contreras-Muñoz7, Jully-Carolina Gómez-Gil2, Carlos-Alberto Calderón-Ospina5.   

Abstract

AIMS: This study aimed to determine the occurrence of adverse drug reactions (ADRs) that caused admission to the intensive care unit (ICU) of a university hospital.
METHODS: Clinical records were reviewed for patients meeting the inclusion criteria who were admitted to the ICU between September and December 2012. Suspected cases of ADRs were documented. Nine researchers later evaluated causality using the Naranjo Algorithm, preventability using the Schumock and Thornton criteria, and clinical classification based on the dose-time-susceptibility system.
RESULTS: In total, 96 patients presented 108 cases of ADR (13.8%, 95% confidence interval 11.2-16.4%) as the cause of admission. The most frequent ADRs were bradyarrhythmias and upper gastrointestinal bleeding (12%). Therapeutic failure accounted for 20%. The most commonly associated medications were acetylsalicylic acid (16%) and losartan (10%). Forty-six cases were categorized as possible, and only one as definite. According to the dose-time-susceptibility classification, in 82% of the cases, the dosage was collateral (within the therapeutic range), and 90% were independent of time; the factors most associated with susceptibility to ADRs were comorbidities (42%) and age (49%). Forty-four percent of the ADRs were considered possibly preventable.
CONCLUSIONS: ADRs contribute significantly to ICU admissions, and a significant number of ADRs are preventable. National studies are needed to assess their incidence and to establish classification standards to reduce their clinical impact.
© 2016 The British Pharmacological Society.

Entities:  

Keywords:  drug-related side effects and adverse reactions; intensive care units; patient admissions; pharmacovigilance; postmarketing; product surveillance

Mesh:

Year:  2017        PMID: 27905143      PMCID: PMC5401977          DOI: 10.1111/bcp.13199

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  25 in total

Review 1.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

Review 2.  [Evaluation of medication side-effects from an economic perspective].

Authors:  Omar Segura; Carlos Maldonado
Journal:  Biomedica       Date:  2003-12       Impact factor: 0.935

Review 3.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

4.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

5.  Iatrogenic events resulting in intensive care admission: frequency, cause, and disclosure to patients and institutions.

Authors:  Lisa Soleymani Lehmann; Ann Louise Puopolo; Shimon Shaykevich; Troyen A Brennan
Journal:  Am J Med       Date:  2005-04       Impact factor: 4.965

6.  Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission.

Authors:  Consuelo Pedrós; Beatriz Quintana; Mireia Rebolledo; Núria Porta; Antoni Vallano; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2013-12-21       Impact factor: 2.953

Review 7.  Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.

Authors:  Chuenjid Kongkaew; Peter R Noyce; Darren M Ashcroft
Journal:  Ann Pharmacother       Date:  2008-07-01       Impact factor: 3.154

8.  The role of iatrogenic disease in admissions to intensive care.

Authors:  P Trunet; J R Le Gall; F Lhoste; B Regnier; Y Saillard; J Carlet; M Rapin
Journal:  JAMA       Date:  1980-12-12       Impact factor: 56.272

9.  Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.

Authors:  Marieke Grenouillet-Delacre; Hélène Verdoux; Nicholas Moore; Françoise Haramburu; Ghada Miremont-Salamé; Gabriel Etienne; Philip Robinson; Didier Gruson; Gilles Hilbert; Claude Gabinski; Bernard Bégaud; Mathieu Molimard
Journal:  Intensive Care Med       Date:  2007-07-25       Impact factor: 17.440

10.  [Patients admitted to the intensive care unit for iatrogenic disease. Risk factors and consequences].

Authors:  B Darchy; E Le Mière; B Figueredo; E Bavoux; G Cadoux; Y Domart
Journal:  Rev Med Interne       Date:  1998-07       Impact factor: 0.728

View more
  8 in total

1.  Characterization of adverse drug reactions causing admission to an intensive care unit.

Authors:  Camilo Rojas-Velandia; Jair Ruiz-Garzón; Juan-Carlos Moscoso-Alcina; Álvaro Vallejos-Narvaéz; Jenny Castro-Canoa; Yuri Bustos-Martínez; Max Flórez-Cutiva; Mabel Contreras-Muñoz; Jully-Carolina Gómez-Gil; Carlos-Alberto Calderón-Ospina
Journal:  Br J Clin Pharmacol       Date:  2017-01-10       Impact factor: 4.335

2.  Applying DoTS adverse drug reactions classification to reports from hospital stimulated reporting.

Authors:  Andreea Farcas; Noemi Beatrix Bulik; Andreea Popa; Agatha Mensah Achampong; Camelia Bucsa; Cristina Mogosan
Journal:  Eur J Clin Pharmacol       Date:  2018-11-10       Impact factor: 2.953

3.  Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study.

Authors:  Anne-Laure Sennesael; Anne-Sophie Larock; Bérangère Devalet; Valérie Mathieux; Franck Verschuren; Xavier Muschart; Olivia Dalleur; Jean-Michel Dogné; Anne Spinewine
Journal:  Br J Clin Pharmacol       Date:  2018-04-17       Impact factor: 4.335

Review 4.  Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review.

Authors:  Miki Ohta
Journal:  Eur J Clin Pharmacol       Date:  2021-04-07       Impact factor: 2.953

5.  Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients.

Authors:  Jubby Marcela Galvez; Carlos Martin Restrepo; Nora Constanza Contreras; Clara Alvarado; Carlos-Alberto Calderón-Ospina; Nidia Peña; Ricardo A Cifuentes; Daniela Duarte; Paul Laissue; Dora Janeth Fonseca
Journal:  Pharmgenomics Pers Med       Date:  2018-10-16

6.  Drug Therapeutic Failures as a Cause of Admission to an Intensive Care Unit at a University Hospital.

Authors:  Jair Antonio Ruiz-Garzon; Camilo Andrés Rojas-Velandia; Carlos-Alberto Calderon-Ospina
Journal:  J Res Pharm Pract       Date:  2019-10-16

7.  Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands.

Authors:  Fouzia Lghoul-Oulad Saïd; Karin Hek; Linda E Flinterman; Ron Mc Herings; Margaretha F Warlé-van Herwaarden; Sandra de Bie; Vera E Valkhoff; Jelmer Alsma; Mees Mosseveld; Ann M Vanrolleghem; Bruno Hch Stricker; Miriam Cjm Sturkenboom; Peter Agm De Smet; Patricia Mla van den Bemt
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-10-13       Impact factor: 2.890

Review 8.  Patient harm from cardiovascular medications.

Authors:  Chariclia Paradissis; Neil Cottrell; Ian Coombes; Ian Scott; William Wang; Michael Barras
Journal:  Ther Adv Drug Saf       Date:  2021-07-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.